Alaunos Therapeutics, Inc.
NASDAQ:TCRT
1.905 (USD) • At close December 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.005 | 2.922 | 0.398 | 0 | 0 | 0.146 | 6.389 | 6.861 | 4.332 | 1.373 | 0.8 | 0.8 | 0.667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0.002 |
| Cost of Revenue
| 4.803 | 2.759 | 0.74 | 1.128 | 0.629 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -4.798 | 0.163 | -0.342 | -1.128 | -0.629 | 0.146 | 6.389 | 6.861 | 4.332 | 1.373 | 0.8 | 0.8 | 0.667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0.002 |
| Gross Profit Ratio
| -959.6 | 0.056 | -0.859 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Reseach & Development Expenses
| 16.279 | 25.018 | 49.643 | 52.696 | 38.331 | 34.134 | 45.084 | 157.791 | 106.785 | 32.706 | 42.852 | 83.446 | 57.083 | 12.91 | 4.556 | 17.245 | 18.993 | 10.391 | 5.594 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 12.219 | 13.142 | 27.564 | 27.665 | 19.527 | 19.918 | 14.798 | 14.377 | 17.647 | 12.166 | 15.661 | 19.523 | 14.984 | 11.636 | 7.567 | 8.374 | 0.773 | 8.72 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.805 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.219 | 13.142 | 27.564 | 27.665 | 19.527 | 19.918 | 14.798 | 14.377 | 17.647 | 12.166 | 15.661 | 19.523 | 14.984 | 11.636 | 7.567 | 8.374 | 9.578 | 8.72 | 4.194 | 0.039 | 0.035 | 0 | 0 |
| Other Expenses
| 0.971 | 0.529 | -1.202 | 0.385 | 0.813 | 0.631 | 0.465 | 0.134 | 0.012 | -0.005 | -0.579 | -0.013 | 0 | 0 | 0 | 0 | 0 | 10.391 | 0 | 0 | 0 | 0.043 | 0.074 |
| Operating Expenses
| 29.469 | 38.16 | 77.207 | 80.361 | 57.858 | 54.052 | 59.882 | 172.168 | 124.432 | 44.872 | 58.513 | 102.969 | 72.067 | 24.546 | 12.123 | 25.619 | 28.57 | 19.112 | 9.787 | 0.039 | 0.036 | 0.043 | 0.074 |
| Operating Income
| -34.267 | -35.105 | -77.549 | -80.361 | 2.264 | -53.906 | -53.493 | -165.307 | -120.1 | -43.499 | -57.713 | -102.169 | -71.4 | -24.546 | -12.123 | -25.619 | -28.57 | -19.112 | -9.787 | -0.039 | -0.036 | -0.04 | -0.073 |
| Operating Income Ratio
| -6,853.4 | -12.014 | -194.847 | 0 | 0 | -369.219 | -8.373 | -24.094 | -27.724 | -31.682 | -72.141 | -127.711 | -107.046 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.541 | -42.025 |
| Total Other Income Expenses Net
| -0.873 | -2.625 | -1.202 | 0.385 | -59.938 | 0.789 | -0.83 | 0.01 | 0.012 | 11.718 | 0.606 | 6.037 | 7.622 | -8.124 | 4.474 | 0.388 | 1.962 | 1.255 | 0.27 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -35.14 | -37.73 | -78.751 | -79.976 | -117.796 | -53.117 | -54.323 | -165.297 | -120.088 | -31.781 | -57.107 | -96.132 | -63.778 | -32.67 | -7.649 | -25.231 | 0 | -17.857 | 0 | -0.039 | -0.036 | -0.04 | -0.073 |
| Income Before Tax Ratio
| -7,028 | -12.912 | -197.867 | 0 | 0 | -363.815 | -8.503 | -24.092 | -27.721 | -23.147 | -71.384 | -120.165 | -95.619 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.541 | -42.025 |
| Income Tax Expense
| 0 | -0.133 | -1.857 | -1.128 | 60.122 | -0.947 | 2.125 | 0.114 | -0.012 | -23.441 | -1.791 | -12.087 | -15.244 | 16.248 | -8.948 | -0.388 | -1.962 | -1.255 | -0.27 | 0 | 0 | 0 | 0 |
| Net Income
| -35.14 | -37.597 | -76.894 | -78.848 | -177.918 | -53.117 | -54.323 | -165.297 | -120.088 | -31.781 | -57.107 | -96.132 | -63.778 | -32.67 | -7.649 | -25.231 | -26.608 | -17.857 | -9.517 | -0.039 | -0.036 | -0.04 | -0.073 |
| Net Income Ratio
| -7,028 | -12.867 | -193.201 | 0 | 0 | -363.815 | -8.503 | -24.092 | -27.721 | -23.147 | -71.384 | -120.165 | -95.619 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.541 | -42.025 |
| EPS
| -21.97 | -25.97 | -53.8 | -56.42 | -158.9 | -55.52 | -59.5 | -190.15 | -143.63 | -47.14 | -99.67 | -183.58 | -144.94 | -106.52 | -49.65 | -178.25 | -211.94 | -213.06 | -262.83 | -39.44 | -18.31 | -26.73 | -48.55 |
| EPS Diluted
| -21.97 | -25.97 | -53.8 | -56.42 | -158.9 | -55.44 | -59.5 | -190.15 | -143.63 | -47.14 | -99.67 | -183.58 | -144.94 | -106.52 | -49.65 | -178.25 | -211.94 | -213.06 | -262.83 | -39.44 | -18.31 | -26.73 | -48.55 |
| EBITDA
| -30.904 | -31.817 | -74.972 | -78.848 | -117.167 | -53.331 | -53.124 | -165.007 | -119.731 | -43.499 | -56.975 | -102.169 | -71.4 | -32.482 | -7.319 | -24.843 | -26.175 | -17.683 | -9.416 | -5.653 | -0.035 | -0.039 | -0.072 |
| EBITDA Ratio
| -6,180.8 | -11.879 | -191.128 | 0 | 0 | -370.301 | -8.17 | -24.076 | -27.724 | -40.22 | -72.7 | -134.451 | -118.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.23 | -41.59 |